Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Jalpa A Doshi
Affiliation
University of Pennsylvania Perelman School of Medicine
ORCID
Career Start Year
2002
Papers
128
H Index
37
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37772461
Association of race and ethnicity with opioid prescribing for Medicare beneficiaries following total joint replacements.
J Am Geriatr Soc
2024
37960866
Out-of-Pocket Costs for Long-Acting Injectable and Oral Antipsychotics Among Medicare Patients With Schizophrenia.
Psychiatr Serv
2024
37889363
Antiretroviral Treatment Gaps and Adherence Among People with HIV in the U.S. Medicare Program.
AIDS Behav
2024
38050764
Real-world treatment patterns, survival, health resource use and costs among Medicare beneficiaries with diffuse large B-cell lymphoma.
Future Oncol
2024
37976040
Geographic variations of pre-exposure prophylaxis reversal and abandonment among United States counties.
AIDS
2024
36961119
Antipsychotic utilization, healthcare resource use and costs, and quality of care among fee-for-service Medicare beneficiaries with schizophrenia in the United States.
J Med Econ
2023
37713202
Racial and Ethnic Disparities in Long-Acting Injectable Antipsychotic Use in a National Sample of Medicare Beneficiaries With Schizophrenia.
JAMA Netw Open
2023
37732602
Real-world adherence and discontinuation among Medicare beneficiaries initiating venetoclax vs. BTKis in relapsed/refractory chronic lymphocytic leukemia.
Leuk Lymphoma
2023
37497877
Assessing unmet need among elderly Medicare Beneficiaries with Mantle cell lymphoma: an analysis of treatment patterns, survival, healthcare resource utilization, and costs.
Leuk Lymphoma
2023
37870435
Ibrutinib discontinuation and associated factors in a real-world national sample of elderly Medicare beneficiaries with chronic lymphocytic leukemia.
Leuk Lymphoma
2023
35977245
Assessment of US Pharmacies Contracted With Health Care Institutions Under the 340B Drug Pricing Program by Neighborhood Socioeconomic Characteristics.
JAMA Health Forum
2022
35738223
Financial incentives tied to Medicare star ratings: impact on influenza vaccination uptake in Medicare beneficiaries.
Am J Manag Care
2022
35579348
dPQL: a lossless distributed algorithm for generalized linear mixed model with application to privacy-preserving hospital profiling.
J Am Med Inform Assoc
2022
35354802
DLMM as a lossless one-shot algorithm for collaborative multi-site distributed linear mixed models.
Nat Commun
2022
36267250
Impact of Updated Clinical Practice Guidelines on Outpatient Treatment for <i>Clostridioides difficile</i> Infection and Associated Clinical Outcomes.
Open Forum Infect Dis
2022
36201673
SARS-CoV-2 Sequelae and Postdischarge Health Care Visits Over 5 Months Follow-up Among Children Hospitalized for COVID-19 or MIS-C.
Pediatr Infect Dis J
2022
33351068
Variation in US Hospital Mortality Rates for Patients Admitted With COVID-19 During the First 6 Months of the Pandemic.
JAMA Intern Med
2021
33512522
Attributable Cost of Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Infection in a Long-term Care Center.
Clin Infect Dis
2021
34783829
Trends in US Patients Receiving Care for Eating Disorders and Other Common Behavioral Health Conditions Before and During the COVID-19 Pandemic.
JAMA Netw Open
2021
34723852
Novel population-level proxy measures for suboptimal HIV preexposure prophylaxis initiation and persistence in the USA.
AIDS
2021
34595957
Treatment utilization patterns of newly initiated oral anticancer agents in a national sample of Medicare beneficiaries.
J Manag Care Spec Pharm
2021
34652218
Schizophrenia population health management: perspectives of and lessons learned from population health decision makers.
J Manag Care Spec Pharm
2021
34137829
Patient and Hospital Factors Associated With Differences in Mortality Rates Among Black and White US Medicare Beneficiaries Hospitalized With COVID-19 Infection.
JAMA Netw Open
2021
33031604
Burden of Parkinson's Disease by Severity: Health Care Costs in the U.S. Medicare Population.
Mov Disord
2021
33386811
Low Sustainment of High-Dose Oral Medication Regimens for Advanced Parkinson's Disease in Medicare Beneficiaries.
J Parkinsons Dis
2021
31592717
Are Medicaid Coverage Gaps Associated with Higher Health Care Resource Utilization and Costs in Patients with Schizophrenia?
Popul Health Manag
2020
34316631
Use of a medication-based algorithm to identify advanced Parkinson's disease in administrative claims data: Associations with claims-based indicators of disease severity.
Clin Park Relat Disord
2020
33095099
Migraine Patients With Cardiovascular Disease and Contraindications: An Analysis of Real-World Claims Data.
J Prim Care Community Health
2020
32852550
The Changing Characteristics of Technologies Covered by Medicare's New Technology Add-on Payment Program.
JAMA Netw Open
2020
32696684
Comprehensive assessment of patients with irritable bowel syndrome with constipation and chronic idiopathic constipation using deterministically linked administrative claims and patient-reported data: the Chronic Constipation and IBS-C Treatment and Outcomes Real-World Research Platform (CONTOR).
J Med Econ
2020
32113626
Trends and Factors Associated With Insurer Approval of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Prescriptions.
Value Health
2020
32138526
Acute treatment patterns in patients with migraine newly initiating a triptan.
Cephalalgia
2020
32197728
Disease-Modifying Therapy Adherence and Associated Factors in a National Sample of Medicare Patients With Multiple Sclerosis.
Value Health
2020
32223301
Comparison of healthcare resource utilization and costs among patients with migraine with potentially adequate and insufficient triptan response.
Cephalalgia
2020
31336178
Omalizumab Treatment Patterns Among Patients with Asthma in the US Medicare Population.
J Allergy Clin Immunol Pract
2020
31361710
The Impact of Stool Consistency on Bowel Movement Satisfaction in Patients With IBS-C or CIC Treated With Linaclotide or Other Medications: Real-World Evidence From the CONTOR Study.
J Clin Gastroenterol
2019
31297967
Early hypoglycaemia and adherence after basal insulin initiation in a nationally representative sample of Medicare beneficiaries with type 2 diabetes.
Diabetes Obes Metab
2019
31199450
Comparative Survival Associated With Use of Targeted vs Nontargeted Therapy in Medicare Patients With Metastatic Renal Cell Carcinoma.
JAMA Netw Open
2019
31424706
Prescribing Patterns Associated With Biologic Therapies for Psoriasis from a United States Medical Records Database
J Drugs Dermatol
2019
28736929
Impact of Cost-Sharing Increases on Continuity of Specialty Drug Use: A Quasi-Experimental Study.
Health Serv Res
2018
29477394
A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7].
Value Health
2018
29477390
Defining Elements of Value in Health Care-A Health Economics Approach: An ISPOR Special Task Force Report [3].
Value Health
2018
29700170
Real-world treatment and outcomes among older adults with chronic lymphocytic leukemia before the novel agents era.
Haematologica
2018
29261440
Association of Patient Out-of-Pocket Costs With Prescription Abandonment and Delay in Fills of Novel Oral Anticancer Agents.
J Clin Oncol
2018
29326146
Prior Authorization Requirements for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Across US Private and Public Payers.
Circ Cardiovasc Qual Outcomes
2018
29195016
Association of high cost sharing and targeted therapy initiation among elderly Medicare patients with metastatic renal cell carcinoma.
Cancer Med
2018
27967261
A conceptual framework for a long-term economic model for the treatment of attention-deficit/hyperactivity disorder.
Expert Rev Pharmacoecon Outcomes Res
2017
28245653
Synchronized prescription refills and medication adherence: a retrospective claims analysis.
Am J Manag Care
2017
28237192
Advancing High-Quality Value Assessments of Health Care Interventions.
Value Health
2017
29648739
Reducing out-of-pocket cost barriers to specialty drug use under Medicare Part D: addressing the problem of "too much too soon".
Am J Manag Care
2017
1 - 50 of 128
Column Actions
Search
Recommended Authors
Hemalkumar B Mehta
Johns Hopkins Bloomberg School of Public Health
Career Start Year
2012
Number of shared co-authors
0
Rishi J Desai
Harvard Medical School
Career Start Year
2011
Number of shared co-authors
2
Pamala A Pawloski
HealthPartners Institute
Career Start Year
2011
Number of shared co-authors
1
Stacie B Dusetzina
Vanderbilt University School of Medicine, TN Vanderbilt Ingram Cancer Center
Career Start Year
2009
Number of shared co-authors
0
Seth A Seabury
USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Career Start Year
2005
Number of shared co-authors
0
Joshua J Gagne
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
Career Start Year
2005
Number of shared co-authors
4
Mihail Samnaliev
Axtria Inc.
Career Start Year
2005
Number of shared co-authors
0
Christine Y Lu
Harvard Medical School and the Harvard Pilgrim Health Care Institute
Career Start Year
2004
Number of shared co-authors
0
Nilay D Shah
Mayo Clinic
Career Start Year
2002
Number of shared co-authors
1
Soko Setoguchi
Rutgers University Institute for Health, the State University of New Jersey
Career Start Year
2001
Number of shared co-authors
4
Daniel E Ball
Lilly Research Laboratories
Career Start Year
2000
Number of shared co-authors
0
Denys T Lau
37345National Center for Health Statistics
Career Start Year
2000
Number of shared co-authors
1
Joseph S Ross
Yale School of Medicine
Career Start Year
1999
Number of shared co-authors
1
Lesley H Curtis
Duke Clinical Research Institute
Career Start Year
1999
Number of shared co-authors
1
John Hsu
Mongan Institute, Massachusetts General Hospital and Harvard Medical School
Career Start Year
1999
Number of shared co-authors
1
Brian C Lund
Center for Access and Delivery Research and Evaluation (CADRE)
Career Start Year
1998
Number of shared co-authors
0
Emily Beth Devine
University of Washington
Career Start Year
1997
Number of shared co-authors
0
Yong-Fang Kuo
University of Texas Medical Branch at Galveston
Career Start Year
1997
Number of shared co-authors
0
Trudy Millard Krause
School of Public Health, The University of Texas Health Science Center at Houston
Career Start Year
1997
Number of shared co-authors
0
Matthew L Maciejewski
Duke University
Career Start Year
1997
Number of shared co-authors
0
Todd H Wagner
Stanford University School of Medicine
Career Start Year
1996
Number of shared co-authors
1
Sebastian Schneeweiss
Division of Pharmacoepidemiology, Brigham & Women's Hospital, Harvard Medical School
Career Start Year
1996
Number of shared co-authors
1
George Caleb Alexander
Institute of General Practice and Family Medicine, University Hospital
Career Start Year
1996
Number of shared co-authors
1
Ellen Meara
Harvard T.H. Chan School of Public Health
Career Start Year
1995
Number of shared co-authors
0
Thomas M Richards
Center for Population Health IT, Johns Hopkins Bloomberg School of Public Health
Career Start Year
1995
Number of shared co-authors
0
Andrew J Epstein
University of California san francisco
Career Start Year
1993
Number of shared co-authors
1
Dana P Goldman
University of Southern California
Career Start Year
1992
Number of shared co-authors
0
Til St??rmer
University of North Carolina at Chapel Hill
Career Start Year
1988
Number of shared co-authors
0
Elizabeth A Chrischilles
University of Iowa, School of Public Health
Career Start Year
1982
Number of shared co-authors
0
Endel J Orav
Brigham and Women's Hospital
Career Start Year
1982
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Stephen E Kimmel
University of Florida
Co-authored papers
7
John Buresh
Co-authored papers
6
Natalie E Sheils
University of Washington
Co-authored papers
6
David A Asch
University of Pennsylvania, USA Leonard Davis Institute of Health Economics
Co-authored papers
6
Rachel M Werner
University of Pennsylvania
Co-authored papers
6
Yong Chen
the Perelman School of Medicine, University of Pennsylvania
Co-authored papers
2
Judith A Long
Corporal Michael J. Cresenz VA Medical Center
Co-authored papers
2
Amy Nunn
Brown University
Co-authored papers
2
Ebbing Lautenbach
Perelman School of Medicine, University of Pennsylvania
Co-authored papers
2
Yonghua Jing
AbbVie Inc.
Co-authored papers
2
Chongliang Luo
Washington University School of Medicine in St Louis
Co-authored papers
2
Daniel J Rader
Co-authored papers
2
Martijn J Schuemie
University of California los angeles
Co-authored papers
2
Jiang Bian
College of Medicine, University of Florida
Co-authored papers
1
Jerry H Gurwitz
university of massachusetts amherst Chan Medical School
Co-authored papers
1
Patrick B Ryan
Columbia University Irving Medical Center
Co-authored papers
1
Brian L Strom
Center for Pharmacoepidemiology and Treatment Science, Rutgers University
Co-authored papers
1
Chungsoo Kim
Ajou University Graduate School of Medicine
Co-authored papers
1
David W Oslin
Perelman School of Medicine, University of Pennsylvania
Co-authored papers
1
Rae Woong Park
Ajou University Graduate School of Medicine
Co-authored papers
1
Yong Chen
University of Pennsylvania
Co-authored papers
1
Zhaoyi Chen
University of Florida
Co-authored papers
1
Nicole Brandt
School of Pharmacy, University of Maryland
Co-authored papers
1
Charitha Gowda
Nationwide Children's Hospital Columbus
Co-authored papers
1
Yujia Zhou
The University of Texas Health Science Center at Houston
Co-authored papers
1
Stephen R Pfohl
Stanford University
Co-authored papers
1
Paula J Busse
Icahn School of Medicine at Mount Sinai
Co-authored papers
1
Rui Duan
Harvard T. H. Chan School of Public Health
Co-authored papers
1
Talita Duarte-Salles
Erasmus University Medical Center
Co-authored papers
1
Bruce Kinosian
University of Pennsylvania
Co-authored papers
1
1 - 30